出海雷达

Senior Director, Regulatory Affairs

其他限定地区(需当地身份)
公司Summit Therapeutics
薪资$203,000 - $253,000/年
工作地点United States
地域资格限定地区(需当地身份)
时区要求日间重叠约 9 小时,基本正常作息
用工类型Full Time
发布时间今天
数据来源Himalayas
前往 Himalayas 查看并投递 →
注意地域限制:该职位明确限定在 United States 招聘。如果你是位于中国大陆的求职者,通常需要当地工作身份才能投递,或需与雇主确认是否接受独立合同(Contractor)形式合作。
关于本页中文:职位描述由本机离线模型翻译,属机器翻译,供快速判断用;正式沟通与投递请以英文原文为准。官方翻译通道恢复后会自动重译升级。

关于峰会:峰会治疗公司是一家生物制药肿肿瘤学公司,其使命是改善生活质量,增加潜在寿命和解决严重未满足的医疗需求。在峰会上,我们相信建立一个热衷于这一任务的世界级专业人员团队,并是我们的员工推动这项使命实现现实。峰会核心价值观包括诚信,卓越的激情,有目的的紧迫性,合作以及我们对人民的承诺。我们的员工真正是我们文化的心脏和灵魂,他们对于塑造我们向卓越的旅程具有无可估计的作用。峰会团队通过 Cummit 在肿肿瘤学领域的临床研究获得启发,帮助改变生活.Summit 有多项全球3期临床研究,包括:非小细胞肺癌 (NSCLC) · HARMONi:第三期临床调查,该研究旨在评估与化疗相比,IVonescimab 和安慰剂加上化学治疗 EGFR 突变,本地先进或转移性非立体 NSCLC 患者中,这些患者以前接受了第三代 EGFR TKI 治疗。· HARMONI-3: · HARMONi-7: 3 期临床研究,旨在评估第一线转移性 NSCLC 患者的 IVonescimab 单疗与 pembrolizumab 单治疗。大肠癌 (CRC) · HARMONI-GI3: 第三阶段临床研究旨在评估 IVonescimib 与化疗相比与 bevacizumab 加上化疗.Ivonescimab 是一种目前未经中国国家医药管理局 (NMPA) 批准的试验疗法。峰会总部位于佛罗里达州迈阿密,加利福尼亚州,新泽西州,英国和爱尔兰。角色概述:监管事务高级主任负责制定和实施全球战略以确保各种研究的 IND/CTA 批准以及为产品在瘤治疗领域后续全球营销应用程序 (BLA/MAA) 的规划和执行提供监管领导力。作用和责任:· 在开发的所有阶段中领导分配产品/指示的全球监管策略。· 可以要求支持监管事务作为

查看英文原文

About Summit:

Summit Therapeutics Inc. is a biopharmaceutical oncology company with a mission focused on improving quality of life, increasing potential duration of life, and resolving serious unmet medical needs. At Summit, we believe in building a team of world class professionals who are passionate about this mission, and it is our people who drive this mission to reality. Summit’s core values include integrity, passion for excellence, purposeful urgency, collaboration, and our commitment to people. Our employees are truly the heart and soul of our culture, and they are invaluable in shaping our journey toward excellence.

Summit’s team is inspired to touch and help change lives through Summit’s clinical studies in the field of oncology. Summit has multiple global Phase 3 clinical studies, including:

Non-small Cell Lung Cancer (NSCLC)

  • HARMONi: Phase 3 clinical study which was intended to evaluate ivonescimab combined with chemotherapy compared to placebo plus chemotherapy in patients with EGFR-mutated, locally advanced or metastatic non-squamous NSCLC who were previously treated with a 3rd generation EGFR TKI.
  • HARMONi-3: Phase 3 clinical study which is intended to evaluate ivonescimab combined with chemotherapy compared to pembrolizumab combined with chemotherapy in patients with first-line metastatic NSCLC.
  • HARMONi-7: Phase 3 clinical study which is intended to evaluate ivonescimab monotherapy compared to pembrolizumab monotherapy in patients with first-line metastatic NSCLC.

Colorectal Cancer (CRC)

  • HARMONi-GI3: Phase 3 clinical study intended to evaluate ivonescimab in combination with chemotherapy compared with bevacizumab plus chemotherapy.

Ivonescimab is an investigational therapy not presently approved by any regulatory authority other than China’s National Medical Products Administration (NMPA). Summit is headquartered in Miami, Florida, and has additional offices in California, New Jersey, the UK, and Ireland.

Overview of Role:
The Senior Director of Regulatory Affairs is responsible for developing and implementing global strategies to secure IND/CTA approvals for various studies as well as providing regulatory leadership for planning and execution of subsequent global marketing applications (BLA/MAA) for product(s) in the oncology therapeutic area.
Role and Responsibilities:

  • Leads global regulatory strategies for assigned products/indications through all phases of development.
  • May be asked to support Regulatory Affairs as relates to development collaborations and/or partnerships and be the primary point of contact for Summit regulatory to ensure success of partner IND/CTA requirements for studies sponsored by partner
  • Continually expands TA knowledge and ensures strategic messaging and content of global regulatory dossiers, to include development of tumor landscape assessment to inform evolving development strategy.
  • Advises management and cross-functional team members of the effect of current or proposed relevant laws, regulations, guidelines, and standards, etc.
  • May lead the Labeling Regulatory Team for given product(s)/indication(s)
  • Demonstrates excellent understanding of drug development and leadership behaviors consistent with level
  • Accountable for ensuring that corporate goals are met with respect to assigned projects
  • Based on experience and scientific strengths, expands TA knowledge of TA; provides coaching and mentoring for other regulatory members
  • May have direct reports and contributes to the performance management for other RA team members
  • May advance the organization's goals by participating and taking leadership roles in professional associations, industry, and trade groups as appropriate
  • Follows budget allocations

Experience, Education and Specialized Knowledge and Skills:

  • Bachelor's degree in life sciences (pharmacy, biology, chemistry, pharmacology) or related subject; Masters or Doctorate preferred
  • Minimum of 10+ years' experience in pharmaceutical regulatory activities, with experience as lead regulatory product strategist in two or more major regions in addition to the US, such as EU, Japan, or China
  • Experience and direct involvement as related to marketing/license applications (e.g., BLA, NDA, MAA)
  • Requires drug development experience in US & EU
  • Minimum of 5+ years of proven experience in a strategic leadership role with strong project management skills
  • Experience working in a cross-functional environment with multiple stakeholders and influencing cross-functional teams
  • Experience interfacing with major government regulatory authorities
  • Strong communication and proactive negotiation skills
  • Communicate effectively and articulate complex ideas in an easily understandable way
  • Ability to successfully work in a fast-paced, demanding and collaborative environment
  • Travel up to approximately 5%

This is the pay for this position

Pay Transparency

$203,000—$253,000 USD

Actual compensation packages are based on several factors that are unique to each candidate, including but not limited to skill set, depth of experience, certifications, and specific work location. This may be different in other locations due to differences in the cost of labor. The total compensation package for this position may also include bonus, stock, benefits and/or other applicable variable compensation.

Summit does not accept referrals from employment businesses and/or employment agencies in respect of the vacancies posted on this site. All employment businesses/agencies are required to contact Summit’s Talent Acquisition team at to obtain prior written authorization before referring any candidates to Summit.

Summit Therapeutics Inc. is an Equal Opportunity Employer and takes pride in creating and maintaining diverse environment. We do not discriminate in recruitment, hiring, training or promotion or any other employment practices for reasons of race, color, religion, gender, national origin, age, sexual orientation, marital or veteran status, disability, or any other legally protected status.

Originally posted on Himalayas

本页面信息整理自 Himalayas,版权归原发布方所有。职位可能随时关闭,投递请以原始页面为准。 本站只做信息聚合展示,不参与招聘流程,也不向求职者收取任何费用。

该公司其他在招职位

临床合同法律顾问

Summit TherapeuticsUnited States$158,000 - $185,000/年Full Time6 天前
职能支持限定地区(需当地身份)

高级医学总监

Summit TherapeuticsUnited States$253,000 - $317,000/年Full Time7 天前
其他限定地区(需当地身份)

← 返回全部职位